✦ LIBER ✦

A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice

✍ Scribed by Tillmann Cyrus; Yuemang Yao; Tao Ding; Jean Michel Dogné; Domenico Praticò

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BM-573, a thromboxane receptor antagonis

✍ C. Cherdon; S. Rolin; J. Hanson; P.V. Drion; L. de Leval; J.O. Defraigne; J.M. D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Pharmacological Profile and Therapeutic

✍ Ghuysen, Alexandre ;Dogné, Jean-Michel ;Chiap, Patrice ;Rolin, Stéphanie ;Masere 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Activity of a novel dual thromboxane A2r

✍ S. Rolin; J.M. Dogné; C. Michaux; J. Delarge; B. Masereel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 315 KB

BM-573 inhibits the development of early

✍ Céline Cherdon; Stéphanie Rolin; Julien Hanson; Annie Ooms; Laurence de Leval; P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 586 KB